Drug General Information
Drug ID	D0IJ2H
Former ID	DIB001212
Drug Name	FK-584
Drug Type	Small molecular drug
Indication	Central and peripheral nervous diseases [ICD10:G96.9]		Discontinued in Phase 2	[546161]
Company	Fujisawa Pharmaceutical Co Ltd
Structure		Download 2D MOL 3D MOL
Formula	C17H18ClN
Canonical SMILES	C1(C=C[C@H](C1)NC(C)(C)C)(c1ccccc1)c1ccccc1
CAS Number	CAS 138951-54-9
PubChem Compound ID	171539
Target and Pathway
Target(s)	Acetylcholine receptor	Target Info	Modulator	[550892]
KEGG Pathway	Neuroactive ligand-receptor interaction
Reactome	Muscarinic acetylcholine receptors
	Acetylcholine regulates insulin secretion
	Highly sodium permeable acetylcholine nicotinic receptors
	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
WikiPathways	Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
References
Ref 546161	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006686)
Ref 550892	US patent application no. 2005,0261,328, Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.